로딩 중…
지수 로딩 중…
Lexeo Therapeutics, Inc. Common Stock
LXEO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$4.93-1.00%
2026-06-18
Price Chart
Lexeo Therapeutics, Inc. Common Stock+16.27%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $387M |
| Revenue | $0.00 |
| Net Income | $-88M |
| Total Assets | $250M |
| Net Assets | $231M |
| Value | |
| P/B | 1.67x |
| FCF Yield | -25.42% |
| Profitability | |
| ROE | -37.80% |
| ROA | -34.95% |
| Financial Health | |
| Debt Ratio | 8.15% |
| Total Debt | $7M |
| FCF | $-98M |
| Cash | $72M |
| Current Ratio | 14.16x |
| Performance | |
| 1Y Return | 16.27% |
| 1M Return | 10.04% |
| From 52W High | -55.14% |
| 1Y MDD | -61.15% |
| Trading | |
| Volume | 1,078,775 shares |
| Trading Value | $5M |
| Per Share | |
| EPS | $-1.30 |
| BPS | $1.98 |